Middendorp, S., Drent, E., Bisso, A., Baardman, S., Verweij, D., Salcedo, E., . . . Throsby, M. (2023). Immunotherapy: TARGETING OVARIAN CARCINOMA WITH GDT002, A FIRST-IN-CLASS γδTCR-BASED T CELL THERAPY. Cytotherapy (Oxford, England), 25(6), S240. https://doi.org/10.1016/S1465-3249(23)00604-7
Citace podle Chicago (17th ed.)Middendorp, S., et al. "Immunotherapy: TARGETING OVARIAN CARCINOMA WITH GDT002, A FIRST-IN-CLASS γδTCR-BASED T CELL THERAPY." Cytotherapy (Oxford, England) 25, no. 6 (2023): S240. https://doi.org/10.1016/S1465-3249(23)00604-7.
Citace podle MLA (9th ed.)Middendorp, S., et al. "Immunotherapy: TARGETING OVARIAN CARCINOMA WITH GDT002, A FIRST-IN-CLASS γδTCR-BASED T CELL THERAPY." Cytotherapy (Oxford, England), vol. 25, no. 6, 2023, p. S240, https://doi.org/10.1016/S1465-3249(23)00604-7.